Dividends
HCA

HCA Healthcare, Inc. (HCA) Ex-Dividend Date Scheduled for September 15, 2021

HCA Healthcare, Inc. (HCA) will begin trading ex-dividend on September 15, 2021. A cash dividend payment of $0.48 per share is scheduled to be paid on September 30, 2021. Shareholders who purchased HCA prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that HCA has paid the same dividend. At the current stock price of $257.69, the dividend yield is .75%.

The previous trading day's last sale of HCA was $257.69, representing a -1.57% decrease from the 52 week high of $261.80 and a 125.29% increase over the 52 week low of $114.38.

HCA is a part of the Health Care sector, which includes companies such as Universal Health Services, Inc. (UHS) and Tenet Healthcare Corporation (THC). HCA's current earnings per share, an indicator of a company's profitability, is $14.58. Zacks Investment Research reports HCA's forecasted earnings growth in 2021 as 44.53%, compared to an industry average of 35%.

For more information on the declaration, record and payment dates, visit the HCA Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.

Interested in gaining exposure to HCA through an Exchange Traded Fund [ETF]?
The following ETF(s) have HCA as a top-10 holding:

  • iShares U.S. Health Care Providers ETF (HCA)
  • Pacer Funds (HCA)
  • SPDR S&P Health Care Services ETF (HCA)
  • LeaderShares Activist Leaders ETF (HCA)
  • LeaderShares Dynamic Yield ETF (HCA).

The top-performing ETF of this group is COWZ with an increase of 4.79% over the last 100 days. IHF has the highest percent weighting of HCA at 5.59%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

HCA

NASDAQ.com

Nasdaq

Get the latest stock market news, stock information & quotes, data analysis reports, as well as a general overview of the market landscape from Nasdaq.

Read Nasdaq.com's Bio